Tempest Therapeutics Ownership | Who Owns Tempest Therapeutics?


OverviewForecastFinancialsChart

Tempest Therapeutics Ownership Summary


Tempest Therapeutics is owned by 21.21% institutional investors, 0.17% insiders, and 78.63% retail investors. Versant venture management is the largest institutional shareholder, holding 13.59% of TPST shares. Fidelity Extended Market Index is the top mutual fund, with 0.49% of its assets in Tempest Therapeutics shares.

TPST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTempest Therapeutics21.21%0.17%78.63%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustryBiotech Stocks 68.48%9.65%21.87%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Versant venture management3.51M13.59%$2.93M
Blackrock550.24K2.47%$1.21M
Blackrock funding, inc. /de551.86K2.14%$460.53K
Jane street group493.09K1.91%$411.49K
Fmr431.93K1.67%$360.45K
Geode capital management354.28K1.37%$295.66K
Ubs group195.68K0.76%$163.39K
Millennium management189.51K0.73%$158.14K
Vanguard group176.19K0.68%$147.12K
Xtx topco160.81K0.62%$134.19K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Versant venture management3.51M3.37%$2.93M
Ikarian capital105.28K0.01%$87.86K
Xtx topco160.81K0.01%$134.19K
Virtu financial43.10K0.00%$36.00K
Maytech global investments10.00K0.00%$8.35K
Boothbay fund management24.26K0.00%$20.24K
Engineers gate manager lp23.50K0.00%$19.61K
Tower research capital llc (trc)10.92K0.00%$9.12K
Davenport50.00K0.00%$41.73K
Millennium management189.51K0.00%$158.14K

Top Buyers

HolderShares% AssetsChange
Versant venture management3.51M3.37%3.51M
Jane street group493.09K0.00%493.09K
Millennium management189.51K0.00%189.51K
Ubs group195.68K-187.28K
Xtx topco160.81K0.01%136.82K

Top Sellers

HolderShares% AssetsChange
Altium capital management lp---545.00K
Gsa capital partners llp---94.91K
Fullcircle wealth---62.00K
Empower advisory group---35.00K
Tocqueville asset management---32.75K

New Positions

HolderShares% AssetsChangeValue
Versant venture management3.51M3.37%3.51M$2.93M
Jane street group493.09K0.00%493.09K$411.49K
Millennium management189.51K0.00%189.51K$158.14K
Dimensional fund advisors lp25.08K-25.08K$54.93K
Engineers gate manager lp23.50K0.00%23.50K$19.61K

Sold Out

HolderChange
Whittier trust-2.00
Whittier trust co of nevada-11.00
Qube research-27.00
Wells fargo & company/mn-98.00
Group one trading-10.69K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202420-37.50%5,473,11993.35%2117.63%13---100.00%
Sep 30, 20243228.00%2,830,70931.84%1011.76%138.33%525.00%
Jun 30, 202425-21.88%2,147,12215.17%96.60%12-20.00%4-20.00%
Mar 31, 202432-11.11%1,864,298-15.77%124.92%15-42.31%5-
Dec 31, 20233650.00%2,213,399-35.12%152.68%26225.00%5-28.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index221.40K0.49%-1.41K
Vanguard Institutional Extnd Mkt Idx Tr174.01K0.40%-
Fidelity Total Market Index98.24K0.22%-
BlackRock Extended Equity Market K36.10K0.14%-15.00
NT Ext Equity Mkt Idx Fd - L58.95K0.14%-
Northern Trust Extended Eq Market Idx58.95K0.14%47.46K
Fidelity Series Total Market Index49.93K0.11%7.32K
iShares Micro-Cap ETF49.91K0.11%10.46K
NT Ext Equity Mkt Idx Fd - NL39.29K0.09%31.58K
Spartan Extended Market Index Pool F39.12K0.09%1.41K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2024Versant Venture Capital VI, L.P.-Sell$540.04K
Aug 12, 2024Versant Venture Capital VI, L.P.-Sell$426.99K
Jul 03, 2024Brady Stephen R President and CEOBuy$73.85K
Jul 02, 2024Whiting Samuel Chief Medical OfficerBuy$9.95K
Jun 28, 2024Trojanowski Justin Corporate ControllerBuy$16.20K

Insider Transactions Trends


DateBuySell
2024 Q322
2024 Q21-
2024 Q1--
2023 Q4--
2023 Q2--

TPST Ownership FAQ


Who Owns Tempest Therapeutics?

Tempest Therapeutics shareholders are primarily institutional investors at 21.21%, followed by 0.17% insiders and 78.62% retail investors. The average institutional ownership in Tempest Therapeutics's industry, Biotech Stocks , is 68.48%, which Tempest Therapeutics falls below.

Who owns the most shares of Tempest Therapeutics?

Tempest Therapeutics’s largest shareholders are Versant venture management (3.51M shares, 13.59%), Blackrock (550.24K shares, 2.47%), and Blackrock funding, inc. /de (551.86K shares, 2.14%). Together, they hold 18.20% of Tempest Therapeutics’s total shares outstanding.

Does Blackrock own Tempest Therapeutics?

Yes, BlackRock owns 2.47% of Tempest Therapeutics, totaling 550.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock increased its holdings by 42.05K shares, a 8.27% change.

Who is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested?

Versant venture management is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested, with 3.37% of its assets in 3.51M Tempest Therapeutics shares, valued at 2.93M$.

Who is the top mutual fund holder of Tempest Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Tempest Therapeutics shares, with 0.49% of its total shares outstanding invested in 221.4K Tempest Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools